These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 6871918)
1. Human leukocyte interferon in the treatment of selected cancer patients. Peddinani MV; Savery F Clin Ther; 1983; 5(4):336-41. PubMed ID: 6871918 [TBL] [Abstract][Full Text] [Related]
2. Clinical investigation of partially pure and recombinant DNA derived leukocyte interferon in human cancer. Gutterman J; Quesada J Tex Rep Biol Med; 1981-1982; 41():626-33. PubMed ID: 6763369 [No Abstract] [Full Text] [Related]
3. Phase I study of human leukocyte interferon in patients with advanced cancer. Horning SJ; Levine JF; Meyer M; Merigan TC; Rosenberg SA J Biol Response Mod; 1983; 2(1):47-56. PubMed ID: 6196450 [TBL] [Abstract][Full Text] [Related]
4. [Clinical effects of human fibroblast interferon on malignant tumors]. Ezaki K; Okabe K; Inagaki J; Horikoshi N; Inoue K; Aiba K; Domyo M; Nagata T; Ogawa M Gan To Kagaku Ryoho; 1982 Jan; 9(1):31-7. PubMed ID: 7184362 [TBL] [Abstract][Full Text] [Related]
5. [Effects of interferon on various malignancies]. Taguchi T Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457 [TBL] [Abstract][Full Text] [Related]
6. Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma. Grunberg SM; Weiss MH; Russell CA; Spitz IM; Ahmadi J; Sadun A; Sitruk-Ware R Cancer Invest; 2006 Dec; 24(8):727-33. PubMed ID: 17162554 [TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
8. Interferon and doxorubicin in renal cell carcinoma. Muss HB; Welander C; Caponera M; Reavis K; Cruz JM; Cooper MR; Jackson DV; Richards F; Stuart JJ; Spurr CL Cancer Treat Rep; 1985 Jun; 69(6):721-2. PubMed ID: 4016777 [No Abstract] [Full Text] [Related]
9. [The prognosis of neurological cancer patients]. Khil'ko VA; Khlunovskiĭ AN; Starchenko AA; Komarets SA Vestn Khir Im I I Grek; 1994; 152(1-2):34-6. PubMed ID: 7701737 [No Abstract] [Full Text] [Related]
10. Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer. Gulley J; Chen AP; Dahut W; Arlen PM; Bastian A; Steinberg SM; Tsang K; Panicali D; Poole D; Schlom J; Michael Hamilton J Prostate; 2002 Oct; 53(2):109-17. PubMed ID: 12242725 [TBL] [Abstract][Full Text] [Related]
11. Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon. García-Buey L; López-Botet M; García-Sánchez A; Balboa MA; Aramburu J; García-Monzón C; Acevedo A; Moreno-Otero R Hepatology; 1993 Mar; 17(3):372-82. PubMed ID: 7680330 [TBL] [Abstract][Full Text] [Related]
12. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Aghi MK; Carter BS; Cosgrove GR; Ojemann RG; Amin-Hanjani S; Martuza RL; Curry WT; Barker FG Neurosurgery; 2009 Jan; 64(1):56-60; discussion 60. PubMed ID: 19145156 [TBL] [Abstract][Full Text] [Related]
13. The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer. Daliani DD; Eisenberg PD; Weems J; Lord R; Fueger R; Logothetis CJ J Urol; 1995 May; 153(5):1587-91. PubMed ID: 7536271 [TBL] [Abstract][Full Text] [Related]